SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-20-008696
Filing Date
2020-01-30
Accepted
2020-01-30 16:11:49
Documents
4
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G a20-6169_1sc13g.htm SC 13G 91777
2 EX-99.1 a20-6169_1ex99d1.htm EX-99.1 22523
3 EX-99.2 a20-6169_1ex99d2.htm EX-99.2 8785
4 EX-99.3 a20-6169_1ex99d3.htm EX-99.3 13286
  Complete submission text file 0001104659-20-008696.txt   137988
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Subject) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-91023 | Film No.: 20561510
SIC: 2834 Pharmaceutical Preparations